[Ca2+, Mg2+-ATPase activity of the erythrocyte membrane in patients with lung cancer].
The activity of erythrocyte membrane Ca2+, Mg2+-ATPase (EC 3.6.1.3) was studied in 22 patients suffering from lung cancer. The enzyme activity was found to increase. The observed changes indicate significant disturbances in the mechanisms of ion transport in organs and tissues during tumour growth.
D000230:Adenocarcinoma / Q000201:enzymology; D000328:Adult; D000368:Aged; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases / Q000097:blood*; D018288:Carcinoma, Small Cell / Q000201:enzymology; D002294:Carcinoma, Squamous Cell / Q000201:enzymology; D004910:Erythrocyte Membrane / Q000201:enzymology*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000201:enzymology*; D008297:Male; D008875:Middle Aged
D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases
Aktivnost' Ca2+, Mg2+-ATFazy membran éritrotsitov u bol'nykh rakom legkogo.